NASDAQ:UPC Universe Pharmaceuticals (UPC) Stock Price, News & Analysis $4.15 -0.03 (-0.72%) Closing price 10/9/2026 03:59 PM EasternExtended Trading$4.21 +0.06 (+1.47%) As of 10/9/2026 05:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsSEC Filings About Universe Pharmaceuticals Stock (NASDAQ:UPC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get UPC alerts:Sign Up Key Stats Today's Range$3.96▼$4.2150-Day Range$3.88▼$7.0952-Week Range$2.00▼$17.96Volume12,062 shsAverage Volume62,193 shsMarket Capitalization$20.83 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Universe Pharmaceuticals Inc. (NASDAQ: UPC) is a China-based pharmaceutical company engaged in the development, manufacture and sale of traditional Chinese medicine (TCM) products and other healthcare offerings. The company serves consumers primarily through pharmaceutical distributors, retail pharmacies and other sales channels in China. Universe Pharmaceuticals’ product portfolio includes over-the-counter and prescription pharmaceutical products, as well as healthcare and nutritional products. Its offerings are derived in part from traditional Chinese medicine formulations and are intended to address a range of consumer health needs. The company also provides related product distribution and marketing services. Founded in 1998, Universe Pharmaceuticals is headquartered in Xi’an, Shaanxi Province, China. Its operations and primary market are concentrated in mainland China. The company completed its initial public offering on the Nasdaq Capital Market in 2021.AI Generated. May Contain Errors. Read More Universe Pharmaceuticals Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks21st Percentile Overall ScoreUPC MarketRank™: Universe Pharmaceuticals scored higher than 21% of companies evaluated by MarketBeat, and ranked 800th out of 883 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingUniverse Pharmaceuticals has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageUniverse Pharmaceuticals has only been the subject of 1 research reports in the past 90 days.Read more about Universe Pharmaceuticals' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioUniverse Pharmaceuticals has a P/B Ratio of 0.04. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.05% of the float of Universe Pharmaceuticals has been sold short.Short Interest Ratio / Days to CoverUniverse Pharmaceuticals has a short interest ratio ("days to cover") of 1.08, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Universe Pharmaceuticals has recently decreased by 42.16%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldUniverse Pharmaceuticals does not currently pay a dividend.Dividend GrowthUniverse Pharmaceuticals does not have a long track record of dividend growth. News and Social Media2.3 / 5News Sentiment0.61 News SentimentUniverse Pharmaceuticals has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Universe Pharmaceuticals this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for UPC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Universe Pharmaceuticals insiders have not sold or bought any company stock.Percentage Held by Insiders57.38% of the stock of Universe Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions0.18% of the stock of Universe Pharmaceuticals is held by institutions.Read more about Universe Pharmaceuticals' insider trading history. Receive UPC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Universe Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. UPC Stock News HeadlinesThe Law Offices of Frank R. Cruz Announces Investigation of Universe Pharmaceuticals INC. (UPC) on Behalf of InvestorsOctober 7 at 5:22 PM | tmcnet.comThe Law Offices of Frank R. Cruz Announces Investigation of Universe Pharmaceuticals INC.October 7 at 5:00 PM | businesswire.comTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery.October 10 at 1:00 AM | Behind the Markets (Ad)Universe Pharmaceuticals shares rise 22.6% premarket with no new catalyst identifiedSeptember 2, 2026 | msn.comUniverse Pharmaceuticals (UPC) stock soars over 38% after-hours: Here's what's going onSeptember 2, 2026 | msn.comUniverse Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:UPCJuly 18, 2026 | benzinga.comUniverse Pharmaceuticals INC - Ordinary Shares - Class AJuly 17, 2026 | money.usnews.comUniverse Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:UPC | BenzingaJune 29, 2026 | benzinga.comSee More Headlines UPC Stock Analysis - Frequently Asked Questions How have UPC shares performed this year? Universe Pharmaceuticals' stock was trading at $3.81 at the start of the year. Since then, UPC stock has increased by 8.9% and is now trading at $4.15. How were Universe Pharmaceuticals' earnings last quarter? Universe Pharmaceuticals INC (NASDAQ:UPC) released its earnings results on Wednesday, July, 29th. The company reported ($1.38) EPS for the quarter. The firm had revenue of $4.52 million for the quarter. When did Universe Pharmaceuticals' stock split? Shares of Universe Pharmaceuticals reverse split on Wednesday, November 13th 2024.The 1-15 reverse split was announced on Wednesday, November 13th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, November 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. When did Universe Pharmaceuticals IPO? Universe Pharmaceuticals (UPC) raised $30 million in an initial public offering (IPO) on Tuesday, March 23rd 2021. The company issued 5,000,000 shares at a price of $5.00-$7.00 per share. Univest Securities, LLC served as the underwriter for the IPO. How do I buy shares of Universe Pharmaceuticals? Shares of UPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings7/29/2026Today10/10/2026Fiscal Year End9/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 UPC's financial health is in the Yellow zone, according to TradeSmith. UPC has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:UPC Previous SymbolNYSE:UPC CIK1809616 Webwww.universe-pharmacy.com Phone86-0796-8403309FaxN/AEmployees216Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.04 Current Ratio4.05 Quick Ratio3.90 Sales & Book Value Annual Sales$17.86 million Price / Sales1.17 Cash FlowN/A Price / Cash FlowN/A Book Value$99.64 per share Price / Book0.04Miscellaneous Outstanding Shares5,020,000Free Float2,141,000Market Cap$20.83 million OptionableN/A Beta1.68 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:UPC) was last updated on 10/10/2026 by MarketBeat.com Staff. From Our PartnersTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTech expert smashes iPhone with golf clubTwenty years ago, Josh Baylin told Congress the iPhone was coming, three years before it launched. A $1,500 be...Stansberry Research | SponsoredElon’s Hiding a Potential $20 Trillion Monster Inside TeslaElon Musk says there is a product inside Tesla's factories he calls the biggest ever made, ten times bigger th...StocksToTrade | SponsoredBanking NightmareDuring the 2008 financial crisis, 485 US banks failed. Martin D. Weiss called 484 of them, a 99.8% accuracy ra...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Universe Pharmaceuticals With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
